Abstract
Aim
To examine the association between placenta previa and adverse perinatal outcomes such as low birth weight, preterm delivery, stillbirth and fetal growth restriction (FGR).
Methods
This retrospective cohort study includes 12,034 delivered pregnant women who were recruited for the study between 2004 and 2010 in Ege University Hospital. Data were collected by browsing the clinic’s archives. The association between placenta previa and adverse perinatal outcomes was determined via Chi-square tests and Student’s t test. Logistic regression analysis was used to adjust for confounding factors in evaluating the association between placenta previa and the adverse perinatal outcomes.
Results
There was no significant relationship between placenta previa and FGR or stillbirth. Low birth weight and preterm delivery were significantly higher in the placenta previa group. According to logistic regression analysis, low birth weight was associated with an OR of 3.01 (95 % CI 2.05–4.52) and preterm delivery was associated with an OR of 8.14 (95 % CI 5.60–11.83); while, placenta previa did not affect FGR and stillbirth significantly.
Conclusion
Although there is no consensus on the association between placenta previa and FGR in previous studies, we suggest that placenta previa is not a reason for placental insufficiency. Management of placenta previa especially depends on maternal hemodynamic parameters such as heavy hemorrhage and hypotensive shock rather than fetal well-being protocols based on serial growth ultrasound and fetal Doppler investigation.
Similar content being viewed by others
References
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY (2010) Obstetrical hemorrhage. Williams obstetrics, 23rd edn. The McGraw-Hill Companies, USA, pp 757–803
Hull AD, Resnick R (2009) Placenta previa, placenta accreta, abruptio placentae, and vasa previa. In: Creasy RK, Resnick R, Iams JD, Lockwood CJ, Moore TR (eds) Creasy and Resnik’s maternal fetal medicine principles and practice, 6th edn. Saunders/Elsevier, Philadelphia (PA), pp 725–737
Oyelese Y, Smulian JC (2006) Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 107:927–941
Rosenberg T, Pariente G, Sergienko R, Wiznitzer A, Sheiner E (2011) Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet 28:47–51
Naeye RL (1978) Placenta previa. Predisposing factors and effects on the fetus and surviving infants. Obstet Gynecol 52:521–525
Neri A, Gorodesky I, Bahary C, Ovadia Y (1980) Impact of placenta previa on intrauterine fetal growth. Isr J Med Sci 16:429–432
Newton ER, Barss V, Cetrulo CL (1984) The epidemiology and clinical history of asymptomatic midtrimester placenta previa. Am J Obstet Gynecol 148:743–748
Chapman MG, Furness ET, Jones WR, Sheat JH (1979) Significance of the ultrasound location of placental site in early pregnancy. Br J Obstet Gynaecol 86:846–848
Brar HS, Platt LD, DeVore GR, Horenstein J (1988) Fetal umbilical velocimetry for the surveillance of pregnancies complicated by placenta previa. J Reprod Med 33:741–744
Ananth CV, Demissie K, Smulian JC, Vintzileos AM (2001) Relationship among placenta previa, fetal growth restriction, and preterm delivery: a population-based study. Obstet Gynecol 98:299–306
Wolf EJ, Mallozzi A, Rodis JF, Egan JFX, Vintzileos AM, Campbell WA (1991) Placenta previa is not an independent risk factor for a small for gestational age infant. Obstet Gynecol 77:707–709
Harper LM, Odibo AO, Macones GA, Crane JP, Cahill AG (2010) Effect of placenta previa on fetal growth. Am J Obstet Gynecol 203:330.e1–330.e5
Brenner WE, Edelman DA, Hendricks CH (1978) Characteristics of patients with placenta previa and results of “expectant management”. Am J Obstet Gynecol 132:180–191
Crane JM, van den Hof MC, Dodds L, Armson BA, Liston R (1999) Neonatal outcomes with placenta previa. Obstet Gynecol 93:541–544
Bukowski R (2010) Stillbirth and fetal growth restriction. Clin Obstet Gynecol 53:673–680
Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M (1996) A United States national reference for fetal growth. Obstet Gynecol 87:163–168
Davey DA, MacGillivray I (1988) The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892–898
MacDorman MF, Kirmeyer S (2009) Fetal and perinatal mortality, United States, 2005. Natl Vital Stat Rep 57:1–19
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY (2010) Preterm birth. Williams obstetrics, 23rd edn. The McGraw-Hill Companies, USA, pp 804–831
American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29:43–48
Sankaran S, Kyle PM (2009) Aetiology and pathogenesis of IUGR. Best Pract Res Clin Obstet Gynaecol 23:765–777
Jarvis S, Glinianaia SV, Torrioli MG, Platt MJ, Miceli M, Jouk PS, Johnson A, Hutton J, Hemming K, Hagberg G, Dolk H, Chalmers J (2003) Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet 362:1106–1111
Barker DJ (2006) Adult consequences of fetal growth restriction. Clin Obstet Gynecol 49:270–283
Baschat AA, Odibo AO (2011) Timing of delivery in fetal growth restriction and childhood development: some uncertainties remain. Am J Obstet Gynecol 204:2–3
Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Mathews TJ, Kirmeyer S, Osterman MJ (2010) Births: final data for 2007. Natl Vital Stat Rep 58:1–85
Schaaf J, Mol B, Abu-Hanna A, Ravelli A (2011) Trends in preterm birth: singleton and multiple pregnancies in the Netherlands, 2000–2007. BJOG. doi:10.1111/j.1471-0528.2011.03010.x
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yeniel, A.O., Ergenoglu, A.M., Itil, I.M. et al. Effect of placenta previa on fetal growth restriction and stillbirth. Arch Gynecol Obstet 286, 295–298 (2012). https://doi.org/10.1007/s00404-012-2296-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2296-4